Ray Dalio acquired 5.25 Thousand Sarepta Therapeutics shares worth $190 Thousand. That's 0.00% of their equity portfolio (647th largest holding). The first Sarepta Therapeutics trade was made in Q1 2021. Since then Ray Dalio bought shares five more times and sold shares on eight occasions. The investor's estimated purchase price is $644 Thousand, resulting in a loss of 70%.